<div class="container">

<table style="width: 100%;"><tr>
<td>MetaAnalyticSurvCat</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Compute surrogacy measures for a categorical (ordinal) surrogate and a time-to-event true endpoint in the meta-analytic multiple-trial setting.</h2>

<h3>Description</h3>

<p>The function 'MetaAnalyticSurvCat()' fits the model for a categorical (ordinal) surrogate and time-to-event true endpoint developed by Burzykowski et al. (2004) in the meta-analytic multiple-trial setting.
</p>


<h3>Usage</h3>

<pre><code class="language-R">MetaAnalyticSurvCat(
  data,
  true,
  trueind,
  surrog,
  trt,
  center,
  trial,
  patientid,
  adjustment
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>data</code></td>
<td>
<p>A data frame with the correct columns (See Data Format).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>true</code></td>
<td>
<p>Observed time-to-event (true endpoint).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>trueind</code></td>
<td>
<p>Time-to-event indicator.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>surrog</code></td>
<td>
<p>Ordinal surrogate endpoint, coded as 1 2 3 ... K.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>trt</code></td>
<td>
<p>Treatment indicator, coded as 0 or 1.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>center</code></td>
<td>
<p>Center indicator (equal to trial if there are no different centers). This is the unit for which specific treatment effects are estimated.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>trial</code></td>
<td>
<p>Trial indicator. This is the unit for which common baselines are to be used.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>patientid</code></td>
<td>
<p>Patient indicator.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>adjustment</code></td>
<td>
<p>The adjustment that should be made for the trial-level surrogacy, either "unadjusted", "weighted" or "adjusted"</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>Returns an object of class "MetaAnalyticSurvCat" that can be used to evaluate surrogacy and contains the following elements:
</p>

<ul>
<li>
<p> Indiv.Surrogacy: a data frame that contains the Global Odds and 95% confidence interval to evaluate surrogacy at the individual level.
</p>
</li>
<li>
<p> Trial.R2: a data frame that contains the <code class="reqn">R^2_{trial}</code> and 95% confidence interval to evaluate surrogacy at the trial level.
</p>
</li>
<li>
<p> EstTreatEffects: a data frame that contains the estimated treatment effects and sample size for each trial.
</p>
</li>
<li>
<p> nlm.output: output of the maximization procedure (nlm) to maximize the likelihood function.
</p>
</li>
</ul>
<h3>Model</h3>

<p>In the model developed by Burzykowski et al. (2004), a copula-based model is used for the true endpoint and a latent continuous variable, underlying the surrogate endpoint.
More specifically, the Plackett copula is used. The marginal model for the surrogate endpoint is a proportional odds model. For the true endpoint, the proportional hazards model is used.
The quality of the surrogate at the individual level can be evaluated by using the copula parameter <code class="reqn">\Theta</code>, which takes the form of a global odds ratio.
The quality of the surrogate at the trial level can be evaluated by considering the <code class="reqn">R^2_{trial}</code> between the estimated treatment effects.
</p>


<h3>Data Format</h3>

<p>The data frame must contains the following columns:
</p>

<ul>
<li>
<p> a column with the observed time-to-event (true endpoint)
</p>
</li>
<li>
<p> a column with the time-to-event indicator: 1 if the event is observed, 0 otherwise
</p>
</li>
<li>
<p> a column with the ordinal surrogate endpoint: 1 2 3 ... K
</p>
</li>
<li>
<p> a column with the treatment indicator: 0 or 1
</p>
</li>
<li>
<p> a column with the trial indicator
</p>
</li>
<li>
<p> a column with the center indicator. If there are no different centers within each trial, the center indicator is equal to the trial indicator
</p>
</li>
<li>
<p> a column with the patient indicator
</p>
</li>
</ul>
<h3>Author(s)</h3>

<p>Dries De Witte
</p>


<h3>References</h3>

<p>Burzykowski, T., Molenberghs, G., &amp; Buyse, M. (2004). The validation of surrogate end points by using data from randomized clinical trials: a case-study in advanced colorectal cancer. Journal of the Royal Statistical Society Series A: Statistics in Society, 167(1), 103-124.
</p>


<h3>Examples</h3>

<pre><code class="language-R">## Not run: 
data("colorectal4")
fit &lt;- MetaAnalyticSurvCat(data = colorectal4, true = truend, trueind = trueind, surrog = surrogend,
                           trt = treatn, center = center, trial = trialend, patientid = patid,
                           adjustment="unadjusted")
print(fit)
summary(fit)
plot(fit)

## End(Not run)
</code></pre>


</div>